Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation
Servier
Servier
Taproot Health
TopAlliance Biosciences
Celgene
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Sarcoma Alliance for Research through Collaboration
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Celldex Therapeutics
Rutgers, The State University of New Jersey
Valerio Therapeutics
Valerio Therapeutics
INSYS Therapeutics Inc
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Case Comprehensive Cancer Center